Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study.
acute lung injury
lung transplantation
organizing pneumonia
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
revised:
05
08
2022
received:
17
02
2022
accepted:
21
08
2022
pubmed:
30
8
2022
medline:
6
12
2022
entrez:
29
8
2022
Statut:
ppublish
Résumé
We determined prognostic implications of acute lung injury (ALI) and organizing pneumonia (OP), including timing relative to transplantation, in a multicenter lung recipient cohort. We sought to understand clinical risks that contribute to development of ALI/OP. We analyzed prospective, histologic diagnoses of ALI and OP in 4786 lung biopsies from 803 adult lung recipients. Univariable Cox regression was used to evaluate the impact of early (≤90 days) or late (>90 days) posttransplant ALI or OP on risk for chronic lung allograft dysfunction (CLAD) or death/retransplantation. These analyses demonstrated late ALI/OP conferred a two- to threefold increase in the hazards of CLAD or death/retransplantation; there was no association between early ALI/OP and these outcomes. To determine risk factors for late ALI/OP, we used univariable Cox models considering donor/recipient characteristics and posttransplant events as candidate risks. Grade 3 primary graft dysfunction, higher degree of donor/recipient human leukocyte antigen mismatch, bacterial or viral respiratory infection, and an early ALI/OP event were significantly associated with increased late ALI/OP risk. These data from a contemporary, multicenter cohort underscore the prognostic implications of ALI/OP on lung recipient outcomes, clarify the importance of the timing of these events, and identify clinical risks to target for ALI/OP prevention.
Identifiants
pubmed: 36031951
doi: 10.1111/ajt.17183
pii: S1600-6135(23)00051-5
pmc: PMC9925227
mid: NIHMS1869000
doi:
Types de publication
Multicenter Study
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3002-3011Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL138256
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI113315
Pays : United States
Organisme : NIAID NIH HHS
ID : UM2 AI117870
Pays : United States
Organisme : NIH HHS
ID : UM2AI117870
Pays : United States
Informations de copyright
© 2022 The American Society of Transplantation and the American Society of Transplant Surgeons.
Références
Int Stat Rev. 2017 Aug;85(2):185-203
pubmed: 29307954
Am J Respir Crit Care Med. 2004 Nov 1;170(9):1022-6
pubmed: 15297270
Transplant Direct. 2018 Jul 11;4(8):e370
pubmed: 30255130
J Heart Lung Transplant. 2019 May;38(5):493-503
pubmed: 30962148
J Heart Lung Transplant. 2017 Oct;36(10):1097-1103
pubmed: 28942784
J Heart Lung Transplant. 2012 Apr;31(4):354-63
pubmed: 22330935
Am J Transplant. 2016 Apr;16(4):1216-28
pubmed: 26845386
Am J Respir Crit Care Med. 2013 Mar 1;187(5):518-26
pubmed: 23328531
Am J Respir Crit Care Med. 2013 Nov 1;188(9):1117-25
pubmed: 24063316
J Heart Lung Transplant. 2013 Jan;32(1):70-7
pubmed: 23260706
Am J Transplant. 2022 Sep;22(9):2169-2179
pubmed: 35634722
J Heart Lung Transplant. 2007 Oct;26(10):1004-11
pubmed: 17919620
J Heart Lung Transplant. 2019 Oct;38(10):1042-1055
pubmed: 31548030
Am J Respir Crit Care Med. 2013 Jun 15;187(12):1360-8
pubmed: 23614642
J Heart Lung Transplant. 2007 Dec;26(12):1229-42
pubmed: 18096473
J Heart Lung Transplant. 2016 Apr;35(4):397-406
pubmed: 27044531
Eur Respir J. 2020 Sep 3;56(3):
pubmed: 32381491
Am J Transplant. 2005 Aug;5(8):2022-30
pubmed: 15996255
J Heart Lung Transplant. 2002 Nov;21(11):1206-12
pubmed: 12431494
Am J Transplant. 2015 Mar;15(3):792-9
pubmed: 25683785